1. Home
  2. CZFS vs BDTX Comparison

CZFS vs BDTX Comparison

Compare CZFS & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Services Inc.

CZFS

Citizens Financial Services Inc.

HOLD

Current Price

$80.49

Market Cap

399.0M

Sector

Finance

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.94

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZFS
BDTX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
399.0M
171.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CZFS
BDTX
Price
$80.49
$1.94
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$9.67
AVG Volume (30 Days)
23.8K
503.7K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
3.10%
N/A
EPS Growth
30.26
130.71
EPS
4.28
N/A
Revenue
$9,881,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.64
N/A
P/E Ratio
$19.07
N/A
Revenue Growth
2.82
N/A
52 Week Low
$52.35
$1.60
52 Week High
$84.35
$4.94

Technical Indicators

Market Signals
Indicator
CZFS
BDTX
Relative Strength Index (RSI) 45.65 43.63
Support Level $78.38 $1.61
Resistance Level $83.95 $2.28
Average True Range (ATR) 1.84 0.09
MACD -0.40 -0.03
Stochastic Oscillator 14.67 12.70

Price Performance

Historical Comparison
CZFS
BDTX

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: